ATE104976T1 - Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number: ATE104976T1
Authority: AT; Austria
Prior art keywords: production; pharmaceutical compositions; compositions containing; morpholine derivatives; physiologically tolerable
Prior art date: 1989-11-06

Application number

AT9090403123T

Other languages

English (en)

Inventor

Gilbert Regnier

Claude Guillonneau

Jean Lepagnol

Pierre Lestage

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-06

Filing date

1990-11-06

Publication date

1994-05-15

1990-11-06 Application filed by Adir filed Critical Adir

1994-05-15 Application granted granted Critical

1994-05-15 Publication of ATE104976T1 publication Critical patent/ATE104976T1/de

Links

YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical class C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
230000032683 aging Effects 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
230000002490 cerebral effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000000302 ischemic effect Effects 0.000 abstract 1
150000002780 morpholines Chemical class 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

AT9090403123T 1989-11-06 1990-11-06 Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE104976T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8914489A FR2653999A1 (fr)	1989-11-06	1989-11-06	Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number	Publication Date
ATE104976T1 true ATE104976T1 (de)	1994-05-15

Family

ID=9387096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT9090403123T ATE104976T1 (de)	1989-11-06	1990-11-06	Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (15)

Country	Link
US (1)	US5026701A (de)
EP (1)	EP0427605B1 (de)
JP (1)	JPH06102660B2 (de)
AT (1)	ATE104976T1 (de)
AU (1)	AU631465B2 (de)
CA (1)	CA2029334A1 (de)
DE (1)	DE69008489T2 (de)
DK (1)	DK0427605T3 (de)
ES (1)	ES2055887T3 (de)
FR (1)	FR2653999A1 (de)
IE (1)	IE66019B1 (de)
NZ (1)	NZ235815A (de)
OA (1)	OA09467A (de)
PT (1)	PT95782B (de)
ZA (1)	ZA908883B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698007A (en) *	1992-08-06	1997-12-16	Akzo Nobel Nv	Process for agglomerating particulate material
JP3411038B2 (ja) *	1993-09-15	2003-05-26	シンテックス（ユー・エス・エイ）・インコーポレイテッド	ミコフェノール酸モフェチルの結晶質無水物およびその静注用製剤
US20040030131A1 (en) *	2000-10-04	2004-02-12	Martine Keenan	Pharmaceutical compounds
JP4185154B2 (ja) *	2004-04-30	2008-11-26	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	中枢神経系障害治療用の置換モルホリン化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE758766A (fr) *	1969-11-17	1971-05-10	Ici Ltd	Nouveaux derives de la morpholine et de la
FR2612926B1 (fr) *	1987-03-24	1989-06-09	Adir	Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant

1989
- 1989-11-06 FR FR8914489A patent/FR2653999A1/fr active Granted
1990
- 1990-10-24 NZ NZ235815A patent/NZ235815A/en unknown
- 1990-10-25 US US07/603,522 patent/US5026701A/en not_active Expired - Fee Related
- 1990-11-05 AU AU65771/90A patent/AU631465B2/en not_active Ceased
- 1990-11-05 IE IE397290A patent/IE66019B1/en not_active IP Right Cessation
- 1990-11-05 PT PT95782A patent/PT95782B/pt not_active IP Right Cessation
- 1990-11-05 CA CA002029334A patent/CA2029334A1/fr not_active Abandoned
- 1990-11-06 DE DE69008489T patent/DE69008489T2/de not_active Expired - Fee Related
- 1990-11-06 JP JP2300917A patent/JPH06102660B2/ja not_active Expired - Lifetime
- 1990-11-06 ES ES90403123T patent/ES2055887T3/es not_active Expired - Lifetime
- 1990-11-06 DK DK90403123.4T patent/DK0427605T3/da active
- 1990-11-06 ZA ZA908883A patent/ZA908883B/xx unknown
- 1990-11-06 EP EP90403123A patent/EP0427605B1/de not_active Expired - Lifetime
- 1990-11-06 OA OA59884A patent/OA09467A/xx unknown
- 1990-11-06 AT AT9090403123T patent/ATE104976T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
OA09467A (fr)	1992-11-15
IE66019B1 (en)	1995-11-29
AU631465B2 (en)	1992-11-26
AU6577190A (en)	1991-07-11
FR2653999B1 (de)	1994-04-22
PT95782B (pt)	1997-11-28
ES2055887T3 (es)	1994-09-01
FR2653999A1 (fr)	1991-05-10
DE69008489D1 (de)	1994-06-01
CA2029334A1 (fr)	1991-05-07
IE903972A1 (en)	1991-05-08
EP0427605B1 (de)	1994-04-27
US5026701A (en)	1991-06-25
ZA908883B (en)	1991-08-28
NZ235815A (en)	1992-04-28
JPH06102660B2 (ja)	1994-12-14
EP0427605A1 (de)	1991-05-15
DE69008489T2 (de)	1994-10-13
JPH03184978A (ja)	1991-08-12
DK0427605T3 (da)	1994-07-25
PT95782A (pt)	1991-09-13

Similar Documents

Publication	Publication Date	Title
ATE40368T1 (de)	1989-02-15	Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE128458T1 (de)	1995-10-15	Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE124047T1 (de)	1995-07-15	Oxazolopyridinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
UA66852C2 (uk)	2004-06-15	Похідні та аналоги 3-арилпропіонової кислоти, спосіб їх отримання, фармацевтична композиція (варіанти) та спосіб профілактики та/або лікування асоційованих з резистентністю до інсуліну клінічних станів
ATE125537T1 (de)	1995-08-15	1,4-disubstituierte piperazine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3765827D1 (de)	1990-12-06	Gegebenenfalls substituierte, 1-(2'-(bis-(phenyl)-methoxy)-aethyl)-4-(3'-(bis-(phenyl)-methoxy)-propyl)-piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE38988T1 (de)	1988-12-15	Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE145899T1 (de)	1996-12-15	Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen
ATE104976T1 (de)	1994-05-15	Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE3429T1 (de)	1983-06-15	Paromomycin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammenzetzung.
PT93450A (pt)	1990-11-07	Processo para a preparacao de novos derivados azetidinicos de acidos piridinocarboxilicos e de composicoes farmaceuticas que os contem
ATE214051T1 (de)	2002-03-15	Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE89281T1 (de)	1993-05-15	Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU610173B2 (en)	1991-05-16	New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
DE3678470D1 (de)	1991-05-08	Neue 3-pyridylmethylnaphthylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE193703T1 (de)	2000-06-15	N-benzylpiperazinverbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen
DE69017265D1 (de)	1995-04-06	Pyrrolidonderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel.
ATE123776T1 (de)	1995-06-15	Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
IL85231A0 (en)	1988-07-31	Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,pharmaceutical compositions containing same and the use thereof
ATE121724T1 (de)	1995-05-15	Neue salze der 2-(2,6-dichloranilino)- phenylessigsäure, verfahren zu ihrer herstellung und ihre verwendung für topisch anwendbare pharmazeutische zubereitungen.
DE69200810D1 (de)	1995-01-19	Benzoesäureethanolaminesterderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
FR2655042B1 (fr)	1994-01-21	Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE140216T1 (de)	1996-07-15	(cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE139780T1 (de)	1996-07-15	Amidderivate von 1-amino-octahydropyrido(2,1- c>(1,4>oxazin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
GR3024391T3 (en)	1997-11-28	Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date	Code	Title	Description
1994-12-15	UEP	Publication of translation of european patent specification
1999-08-15	REN	Ceased due to non-payment of the annual fee